Ligand Pharmaceuticals (LGND) Minority Interest (2014 - 2015)

Ligand Pharmaceuticals (LGND) reported Minority Interest of -$2.8 million for Q1 2015, down 44.14% sequentially from -$1.9 million in Q4 2014.

Ligand Pharmaceuticals (LGND) Minority Interest (2014 - 2015) Analysis & Trends

Ligand Pharmaceuticals (LGND) has 2 years of Minority Interest data on file, last reported at -$2.8 million in Q1 2015.

For the quarter ending Q1 2015, Minority Interest changed N/A year-over-year to -$2.8 million; the trailing twelve-month figure through Mar 2015 stood at -$2.8 million (changed N/A YoY), and the FY2014 full-year result was -$1.9 million, changed N/A from the prior year.
Minority Interest retreated to -$2.8 million in Q1 2015, from -$1.9 million in the prior quarter.
In the past five years, Minority Interest ranged from a high of -$1.1 million in Q2 2014 to a low of -$2.8 million in Q1 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Ligand Pharmaceuticals	6.05 Bn	5.27 Bn	48.45 Mn

Download Data